IIT Ropar proposes Active Infrared Thermography application method for early breast cancer diagnosis

2018-04-10 09:13:04

IIT Ropar scientists are working towards the development of portable, low cost, an \nactive infrared screening system, which will provide an early detection \nof breast cancer.By Team ABLEThe Indian Institute of Technology Ropar has introduced a novel pulse compression favourable Active Infrared Thermography for early detection of breast cancer in women of all ages, including pregnant or nursing w

Read more

Novartis expands gene therapy business with AveXis acquisition for $USD 8.7 bn

2018-04-10 09:10:05

AveXis lead product candidate, AVXS-101, has potential to be first-ever one-time gene replacement therapy for spinal muscular atrophy (SMA), a disease which results in early death or lifelong disability with considerable healthcare costsBy Team ABLENovartis has entered into an agreement and plan of merger with AveXis, to acquire the US-based Nasdaq-listed clinical stage gene therapy company f

Read more

Merck Foundation calls for Application for Merck Hypertension and Diabetes Awards 2018

2018-04-10 09:08:54

Merck Foundation has announced the call for application for Merck Diabetes and Hypertension awards 2018, across the African and Asian Universities through its Merck Capacity Advancement Program.By Team ABLEMerck Foundation, the Philanthropic arm of Merck KGaA Germany, has announced the call for application for Merck Diabetes and Hypertension awards 2018, across the African and Asian Universities t

Read more

Bharat Biotech unveils new brand identity; Donates Rs 1 crore worth vaccines to celebrate 20 Years of ‘Leading Innovation’

2018-04-09 23:32:36

Over the last 20 years Bharat Biotech has a built a strong portfolio of more than 50 patents, 20+ commercially available safe, affordable and best in class vaccines and bio therapeutic products, accessible in over 100 countries.By Team ABLE Genome Valley based \"Clone-to-Clinic\" Indian biotechnology MNC, Bharat Biotech, unveiled its new corporate logo and its vision for the future. With its new l

Read more

Novo Nordisk get exclusive worldwide licence to EpiDestiny\'s sickle cell disease programme

2018-04-09 23:25:32

Novo Nordisk secures blood drug licence to boost anaemic biopharma businessBy Team ABLENovo Nordisk and EpiDestiny announced that Novo Nordisk has obtained an exclusive worldwide licence to EpiDestiny\'s sickle cell disease (SCD) programme, EPI01.EpiDestiny is eligible to receive more than 400 million US dollars in upfront, development and sales milestone payments and will get royalties on net sal

Read more

Biopharma caught in the crosshairs of US-China trade tussle

2018-04-09 23:24:04

Just a week after Johnson & Johnson chief Alex Gorsky and Novartis CEO Vasant Narasimhan expressed longing for stable and fair trade, biopharmaceuticals and medical devices have been dragged into the $100 billion trade war between the U.S. and China, the world’s two largest economies.Source: https://www.fiercepharma.com/pharma/despite-industry-wishes-biopharmaceuticals-caught-crosshairs-u-s-

Read more

BIO Announces Keynote and Returns to Boston June 4-7 to Celebrate 25 Years of History-Making Innovation

2018-04-09 23:08:46

The BIO International Convention will return to the Boston Convention & Exhibition Center, June 4-7, to celebrate 25 years of advocacy and innovation. By Team ABLEHosted by the Biotechnology Innovation Organization (BIO), the 2018 event is expected to attract more than 16,000 attendees and 1,800 exhibitors from 74 countries – all who will be welcomed in a special, keynote address by ABC’s

Read more

Shrikumar Suryanarayan of Sea6Energy takes over as ABLE President

2018-04-03 23:05:46

A new team of elected Executive Council, led by  Mr Shrikumar Suryanarayan, chairman of Sea6Energy, as President has taken charge at the Association of Biotechnology Led Enterprises (ABLE) on April 1, 2018.By Team ABLEABLE’s new executive committee  led by Shrikumar Suryanarayan  was , elected in November 2017. The team will hold office for the next three years, up to March 31, 20

Read more

“Jerky policies are a deterrent to biotech growth” Dr PM Murali

2018-03-30 07:27:42

DR PANCHAPAGESA MUTHUSWAMY MURALI takes a bow as the President of ABLE on March 31, 2018 after an illustrious three-year tenure as the CEO of India’s biotechnology industry organization, ABLE. This was his second three-year tenure at the helm of ABLE, starting in 2012. During the past years, ABLE has transformed from a small organization

Read more

Dr. Javed N Agrewala bags ‘JC Bose Fellowship’ Award

2018-03-29 09:16:58

Dr Javed of IIT Ropar has been awarded the ‘JC Bose Fellowship’ for his work on the development of novel vaccination strategies against tuberculosis.By Team ABLEDr. Javed N Agrewala, Professor, Centre for Biomedical Research, Indian Institute of Technology Ropar has been awarded the prestigious ‘JC Bose Fellowship’ for his work on the development of novel vaccination strategies against tub

Read more